Amit Kulkarni, MBBS

Dr. Kulkarni is a Medical Oncologist specializing in thoracic malignancies. His research is focused on developing novel biomarkers of immunotherpay response. Dr. Kulkarni also has interest in evaluating the role of microbiome in cancer development and treatment. He also acts as site Principal Investigator for several cancer therapy clinical trials. He joined the faculty in 2020 after completing his fellowship at the University of Minnesota.

• Alliance for Clinical Trials in Oncology Scholar Award (2021)
• Minnesota Cancer Clinical Trials Network Community Site Award (2021)
• COVID-19 Rapid Response Research Grant from the University of Minnesota (2020)
• MSCO Outstanding Fellow Award (2018, 2019, 2020)
• FDA-ASCO Hematology-Oncology Fellow Workshop Award (2020)
• ASCO/AACR Methods in Clinical Cancer Research Workshop Award (2019)
• Outstanding Resident Scholar for Research - Greater Baltimore Medical Center (2017)

• American College of Physicians
• American Society of Clinical Oncology
• American Society of Hematology
• International Association for Study of Lung Cancer
• American Association for Cancer Research
• Society of Immunotherapy in Cancer

• Dr. Kulkarni has special interest in evaluating the role of gut and tumor Microbiome in cancer development and treatment. He also has interest in precision oncology trials and early phase clinical trials.